Expression of Histamine Receptors in the Human Endolymphatic Sac: the Molecular Rationale for Betahistine Use in Menieres Disease

Overview

Journal Eur Arch Otorhinolaryngol

Specialty Otorhinolaryngology

Date 2015 Jul 26

PMID 26208913

Citations 13

Authors

M Nue Moller

S Kirkeby

J Vikesa

F Cilius Nielsen

P Caye-Thomasen

Affiliations

Soon will be listed here.

Abstract

The human endolymphatic sac (ES) is situated in a duplicature of the dura in the posterior cranial fossa and constitutes a part of the inner ear. The sac possesses immunological capacities and is responsible for a major part of the trans-epithelial ion transport occurring within the inner ear, via molecular mechanisms similar to that of the kidney collecting duct epithelia. Dysfunction of the trans-epithelial ion transport has been hypothesized as the reason for the endolymphatic hydrops occurring in Menieres diseases. Thus, candidate drug selection for medical treatment of Menieres disease has been based on a potential capability of improving trans-epithelial ion transport. However, recent human studies seems to rule out diuretic therapy and The Committee for Medicinal Products for Human Use redrew the recommendation for trimetazidine (Vastarel) treatment in the management of Meniere disease in 2012. This leaves betahistine (Betaserc) as the only drug for potential prevention of the incapacitating attacks of dizziness, tinnitus and hearing loss. However, the histamine receptors targeted by betahistine have never been demonstrated in the human ES. Accordingly, this study aims to investigate the expression of histamine receptors of the human ES epithelium and sub-epithelial stroma. Following sampling of human endolymphatic sac tissue during translabyrinthine surgery, the expression of histamine receptor genes was determined by cDNA microarray analysis. Results were subsequently verified by immuno-histochemistry. The combined results of microarrays and immuno-histochemistry showed expression of the histamine receptor HRH1 in the epithelial lining of the ES, whereas HRH3 was expressed exclusively in the sub-epithelial capillary network. Receptors HRH2 and -4 were not expressed. The present data provide the first direct evidence of a molecular rationale for betahistine treatment in Menieres disease. A potential betahistine effect in Menieres disease may primarily be through the H3-receptor antagonism, leading to inhibition of vestibular neuro-transmission and central vaso-dilation. The H1-receptor localization in the ES epithelium suggests an immuno-regulatory effect.

Citing Articles

Optimizing spatial normalization of multisubject inner ear MRI: comparison of different geometry-preserving co-registration approaches.

Gerb J, Kirsch V, Kierig E, Brandt T, Dieterich M, Boegle R Sci Rep. 2025; 15(1):6414.

PMID: 39984604 PMC: 11845522. DOI: 10.1038/s41598-025-90842-2.

World-wide survey on the treatment of peripheral vestibular disorders.

Strupp M, Kern N, Laurell G, Lehner L, Grill E, Strobl R Front Neurol. 2025; 16:1540443.

PMID: 39968460 PMC: 11832385. DOI: 10.3389/fneur.2025.1540443.

Stimulation of histamine H-receptors produces a positive inotropic effect in the human atrium.

Pham T, Rayo Abella L, Hadova K, Klimas J, Dhein S, Pockes S Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39729205 DOI: 10.1007/s00210-024-03735-y.

Histaminergic System and Vestibular Function in Normal and Pathological Conditions.

Tighilet B, Trico J, Marouane E, Zwergal A, Chabbert C Curr Neuropharmacol. 2024; 22(11):1826-1845.

PMID: 38504566 PMC: 11284731. DOI: 10.2174/1570159X22666240319123151.

Examination of betahistine bioavailability in combination with the monoamine oxidase B inhibitor, selegiline, in humans-a non-randomized, single-sequence, two-period titration, open label single-center phase 1 study (PK-BeST).

Strupp M, Churchill G, Naumann I, Mansmann U, Al Tawil A, Golentsova A Front Neurol. 2023; 14:1271640.

PMID: 37920833 PMC: 10619746. DOI: 10.3389/fneur.2023.1271640.

References

Furukawa M, Suzuki H, Ikeda K, Oshima T, Yamaya M, Sasaki H . Kinin and histamine stimulate Cl- secretion in gerbil middle ear epithelium: connection to otitis media. Hear Res. 1999; 132(1-2):109-16. DOI: 10.1016/s0378-5955(99)00042-8. View

Malinowska B, Godlewski G, Schlicker E . Histamine H3 receptors--general characterization and their function in the cardiovascular system. J Physiol Pharmacol. 1998; 49(2):191-211. View

Yabe T, Waele C, Serafin M, Vibert N, Arrang J, Muhlethaler M . Medial vestibular nucleus in the guinea-pig: histaminergic receptors. II. An in vivo study. Exp Brain Res. 1993; 93(2):249-58. DOI: 10.1007/BF00228392. View

Mukhopadhyay S, Niyogi M, Ray R, Mukhopadhyay B, Dutta M, Mukherjee M . Betahistine as an add-on: The magic bullet for postoperative nausea, vomiting and dizziness after middle ear surgery?. J Anaesthesiol Clin Pharmacol. 2013; 29(2):205-10. PMC: 3713669. DOI: 10.4103/0970-9185.111725. View

Lacour M, Van de Heyning P, Novotny M, Tighilet B . Betahistine in the treatment of Ménière's disease. Neuropsychiatr Dis Treat. 2009; 3(4):429-40. PMC: 2655085. View

Dagli M, Goksu N, Eryilmaz A, Kuzey G, Bayazit Y, Dogan Gun B . Expression of histamine receptors (H(1), H(2), and H(3)) in the rabbit endolymphatic sac: an immunohistochemical study. Am J Otolaryngol. 2007; 29(1):20-3. DOI: 10.1016/j.amjoto.2006.12.003. View

Moller M, Kirkeby S, Vikesa J, Nielsen F, Caye-Thomasen P . Gene expression in the human endolymphatic sac: the solute carrier molecules in endolymphatic fluid homeostasis. Otol Neurotol. 2014; 36(5):915-22. DOI: 10.1097/MAO.0000000000000669. View

Salt A, Plontke S . Endolymphatic hydrops: pathophysiology and experimental models. Otolaryngol Clin North Am. 2010; 43(5):971-83. PMC: 2923478. DOI: 10.1016/j.otc.2010.05.007. View

Gbahou F, Davenas E, Morisset S, Arrang J . Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo. J Pharmacol Exp Ther. 2010; 334(3):945-54. DOI: 10.1124/jpet.110.168633. View

10.

Harris J, Heydt J, Keithley E, Chen M . Immunopathology of the inner ear: an update. Ann N Y Acad Sci. 1998; 830:166-78. DOI: 10.1111/j.1749-6632.1997.tb51888.x. View

11.

Nguyen T, Okolo C, Moody M . Histamine stimulates ion transport by dog pancreatic duct epithelial cells through H1 receptors. Am J Physiol. 1998; 275(1):G76-84. DOI: 10.1152/ajpgi.1998.275.1.G76. View

12.

Zhou L, Zhou W, Zhang S, Liu B, Leng Y, Zhou R . Changes in Histamine Receptors (H1, H2, and H3) Expression in Rat Medial Vestibular Nucleus and Flocculus after Unilateral Labyrinthectomy: Histamine Receptors in Vestibular Compensation. PLoS One. 2013; 8(6):e66684. PMC: 3686684. DOI: 10.1371/journal.pone.0066684. View

13.

Moller M, Brandt C, Ostergaard C, Caye-Thomasen P . Endolymphatic sac involvement in bacterial meningitis. Eur Arch Otorhinolaryngol. 2014; 272(4):843-851. DOI: 10.1007/s00405-014-2884-y. View

14.

Kim H, Lee C, Rhee C . Histamine regulates mucin expression through H1 receptor in airway epithelial cells. Acta Otolaryngol. 2012; 132 Suppl 1:S37-43. DOI: 10.3109/00016489.2012.661075. View

15.

Tighilet B, Mourre C, Trottier S, Lacour M . Histaminergic ligands improve vestibular compensation in the cat: behavioural, neurochemical and molecular evidence. Eur J Pharmacol. 2007; 568(1-3):149-63. DOI: 10.1016/j.ejphar.2007.04.052. View

16.

Muller T, Myrtek D, Bayer H, Sorichter S, Schneider K, Zissel G . Functional characterization of histamine receptor subtypes in a human bronchial epithelial cell line. Int J Mol Med. 2006; 18(5):925-31. View

17.

Merchant S, Adams J, Nadol Jr J . Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops?. Otol Neurotol. 2005; 26(1):74-81. DOI: 10.1097/00129492-200501000-00013. View

18.

Kim S, Marcus D . Regulation of sodium transport in the inner ear. Hear Res. 2011; 280(1-2):21-9. PMC: 3176991. DOI: 10.1016/j.heares.2011.05.003. View

19.

SCHUKNECHT H, Suzuka Y, Zimmermann C . Delayed endolymphatic hydrops and its relationship to Meniére's disease. Ann Otol Rhinol Laryngol. 1990; 99(11):843-53. DOI: 10.1177/000348949009901101. View

20.

Tighilet B, Trottier S, Lacour M . Dose- and duration-dependent effects of betahistine dihydrochloride treatment on histamine turnover in the cat. Eur J Pharmacol. 2005; 523(1-3):54-63. DOI: 10.1016/j.ejphar.2005.09.017. View